- Home
- EP vs CRVS Comparison
EP vs CRVS Comparison
Compare EP & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EP
- CRVS
- Stock Information
- Founded
- EP 1983
- CRVS 2014
- Country
- EP United States
- CRVS United States
- Employees
- EP N/A
- CRVS N/A
- Industry
- EP Oil & Gas Production
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- EP Energy
- CRVS Health Care
- Exchange
- EP Nasdaq
- CRVS Nasdaq
- Market Cap
- EP 170.7M
- CRVS 161.4M
- IPO Year
- EP N/A
- CRVS 2016
- Fundamental
- Price
- EP $5.17
- CRVS $5.48
- Analyst Decision
- EP
- CRVS Buy
- Analyst Count
- EP 0
- CRVS 4
- Target Price
- EP N/A
- CRVS $10.83
- AVG Volume (30 Days)
- EP 35.8K
- CRVS 460.2K
- Earning Date
- EP 11-11-2024
- CRVS 11-05-2024
- Dividend Yield
- EP N/A
- CRVS N/A
- EPS Growth
- EP N/A
- CRVS N/A
- EPS
- EP N/A
- CRVS N/A
- Revenue
- EP $42,871,387.00
- CRVS N/A
- Revenue This Year
- EP N/A
- CRVS N/A
- Revenue Next Year
- EP N/A
- CRVS N/A
- P/E Ratio
- EP N/A
- CRVS N/A
- Revenue Growth
- EP N/A
- CRVS N/A
- 52 Week Low
- EP $4.06
- CRVS $1.05
- 52 Week High
- EP $10.99
- CRVS $6.15
- Technical
- Relative Strength Index (RSI)
- EP 50.90
- CRVS 71.40
- Support Level
- EP $4.50
- CRVS $3.90
- Resistance Level
- EP $5.14
- CRVS $4.75
- Average True Range (ATR)
- EP 0.29
- CRVS 0.45
- MACD
- EP 0.01
- CRVS 0.09
- Stochastic Oscillator
- EP 44.97
- CRVS 70.22
About EP Empire Petroleum Corporation
Empire Petroleum Corp is a conventional oil and natural gas producer with a main focus in the US onshore. The company possesses long-life, mature, producing assets with slow decline profiles in the Permian Basin, Bakken region and central Gulf Coast region, in the states of New Mexico, North Dakota, Montana, Louisiana and Texas. It has production from operated and non-operated wells in Lea County in New Mexico, Bottineau, Renville, Burke, and McKenzie Counties in North Dakota, Richland County in Montana, St. Landry, Beauregard Parishes in Louisiana and Houston, Leon and Madison Counties in Texas.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers, and autoimmune diseases. The company's primary product candidate is Soquelitinib (CPI-818), an oral, small-molecule drug that selectively inhibits ITK (interleukin-2-inducible T cell kinase). The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).